Phase
Condition
Alzheimer's Disease
Dementia
Memory Loss
Treatment
N/AClinical Study ID
Ages > 50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Moderate to Severe Alzheimer's Disease with a score greater than or equal to 4 onagitation/aggression domain of NPI
Stable dose of donepezil for 3 months
Exclusion
Exclusion Criteria:
Other evidence of psychiatric disorders
Oncologic diagnosis
Clinically significant gastrointestinal, renal, hepatic, endocrine or cardiovasculardisease
Study Design
Connect with a study center
The Forves Norris MDA/ALS Research Center
San Francisco, California 94115
United StatesSite Not Available
Coastal Communities Hospital
Westminster, California 92683
United StatesSite Not Available
Alzheimer's Disease Research Unit
New Haven, Connecticut 06510
United StatesSite Not Available
Berma Research Group
Hialeah, Florida 33016
United StatesSite Not Available
Baumel-Eisner Neuromedical Institute
Miami, Florida 33154
United StatesSite Not Available
Premiere Research Institute
West Palm Beach, Florida 33407
United StatesSite Not Available
Geriatric Medicine
Honolulu, Hawaii 96817
United StatesSite Not Available
The Memory Clinic
Bennington, Vermont 05201
United StatesSite Not Available
Hampton Roads Center for Clinical Research
Norfolk, Virginia 23502
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.